Table 2 Basic characteristics of the included patients

Abramson, J. S

lymphoma

269

65%

63(54–70)

≥3 lines: 51%

35%

Zhiling Yan

MM

21

48%

58(49.5–61)

mean lines: 6

14%

Ali, S. A

MM

12

median lines: 7

100%

Cohen, A. D

MM

25

68%

58(44–75)

median(range) lines: 7(3–13)

92%

Curran, K. J

ALL

25

13.5(1–22.5)

Not found

20%

Enblad, Gunilla

lymphoma+ALL

15

47%

61(24–71)

mean lines: 1.73

40%

Fry, T. J

B-ALL

21

62%

19(7–30)

Not found

90%

Gardner, R. A

B-ALL

43

44%

12.3(1.3–25.4)

Not found

62%

Geyer, M. B.

CLL

8

100%

58(45–70)

Not found

Geyer, M. B

CLL + NHL

20

70%

63(43–75)

median(range) lines:

4(1–11)

0

Goto, H

DLBCL

9

56%

61(32–73)

mean lines; 3

44.40%

Fried, S.

ALL+NHL

35

71%

27(3.5–55)

Not found

37%

Lee, D. W

ALL+DLBCL

19

67%

1 to 30

mean lines: 2

38%

Locke, F. L

lymphoma

108

68%

Phase 1:

59 (IQR34–69);Phase 2:

58 (IQR51–64)

median lines: 3

23%

Maude, S. L

ALL

75

57%

11(3–23)

median(range) lines:

3(1–8)

61%

Xu, J

MM

17

65%

55(40–73)

median(range) lines:

5(3–11)

47%

Schuster, S. J

DLBCL

111

65%

56 (22–76)

≥3 lines: 52%

49%

Raje, N

MM

33

64%

60(37–75)

median(range) lines: 7(3–23)

97%

Schuster, S. J

FCL + DLBCL

28

64%

57.5(25–77)

median(range) lines: 4.5 (1–10)

39%

Wang, N^a

ALL

51

63%

27 (9–62)

Not found

24%

Wang, N^a

NHL

38

58%

47 (17–71)

Not found

15.80%

Zhao, W. H

MM

57

60%

54 (27–72)

median(range) lines: 3 (1–9)

18%

Wang, M

MM

68

84%

65 (38–79)

≥3lines 81%;

median(range) lines: 3 (1–5)

43%

Sang, W

DLBCL

21

62%

55 (23–72)

median(range) lines: 3(1–6)

5%

Wayne AS,

ALL

24

63%

13(3–20)

≥3 lines: 42%

25%

Ghorashian, S

ALL

14

93%

9.24 (1.35–19.28)

median(range) lines: 4(2–7)

71%

Wang, Jia

ALL

23

61%

42(10–67)

median(range) lines: 2(2–3)

22%

Bao, F.

ALL+NHL

10

40%

33.5(25–69)

Not found

Hu, Jianda

DLBCL

8

52(27–70)

Not found

Jiang, Songfu

MM

16

55 (39–67)

median(range) lines:

4(2–10)

56%

Wierda, William G

ALL

35

51%

40(18–69)

≥3 lines: 60%

Yan, Lingzhi

MM

28

82%

57.5 (42–69)

mean(range) lines: 3(2–8)

Amrolia, Persis J.

ALL

8

7.5(4–16)

Not found

63%

Ardeshna, Kirit

DLBCL

11

49

median lines: 3

27%

Strati, Paolo

lymphoma

31

74%

52(23–76)

>3lines 45%;

median(range) lines: 3(1–11)

35%

Yan, Zi-Xun

NHL

10

80%

47(32–59)

≥3lines: 100%

Ying, Zhitao^b

NHL

3

67%

<65

mean lines: 9.7

0

Ying, Zhitao^b

NHL

3

100%

<65

mean lines: 8

0

Topp, M. S.

lymphoma

21

67%

63 (36–73)

≥2lines: 76%

10%

An, F

ALL

47

49%

22(3–72)

<10lines: 59.6%

19.10%

Dourthe, M. E

ALL

41

18.2(1–29.2)

Not found

63%

Mailankody, S

MM

51

61(33–77)

median(range) lines: 6 (3–18)

Popat, R

MM

11

61 (45–69)

median(range) lines: 5(3–6)

73%

Ramos, C. A

HL

42

67%

35(17–69)

median(range) lines: 7(2–23)

100%

Sesques, P^c

DLBCL

33

72%

62 (28–75)

≥4 lines: 64%

30%

Sesques, P^c

DLBCL

28

57%

59 (27–72)

≥4 lines: 79%

29%

Shah, N. N

lymphoma

22

86%

57 (38–72)

Not found

50%

Tong, C

NHL

28

39%

≥3 lines: 79%

Usmani, S. Z

MM

29

median(range) lines: 5(3–18)

Wang, Y

ALL

21

52%

13 (3–69)

median(range) lines: 4(1–7)

9.52%

Zhou, X

NHL + DLBCL

21

62%

31 to 77

≥4 lines: 38%

Ramos, Carlos A

NHL

16

67(17–73)

Not found

31%

Zhang, W. Y

NHL

11

≥18

Not found

9%

Jain, T

NHL + ALL+MM

83

67%

58(19–85)

Not found

37%

Jacobson, Caron

iNHL

146

57%

61(34–79)

median(range) lines: 3(1–10)